RENAISSANCERE HOLDINGS LTD (RNR)

BMG7496G1033 - Common Stock

189.08  -5.59 (-2.87%)

After market: 190.02 +0.94 (+0.5%)


Fundamental Rating

3

Overall RNR gets a fundamental rating of 3 out of 10. We evaluated RNR against 141 industry peers in the Insurance industry. RNR has a bad profitability rating. Also its financial health evaluation is rather negative. RNR has a correct valuation and a medium growth rate.

Note: RNR has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

0


VS Industry

Valuation

Valuation Rating

5

The Forward Price/Earnings Ratio of 6.53 indicates a rather cheap valuation of RNR.
The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
With a Price/Earnings Ratio of 16.12, RNR is valued correctly.

With a price book ratio of 1.62, RNR is valued correctly.
Compared to an average industry Price/Earning Ratio of 10.54, RNR is valued slightly more expensive.
When comparing the price book ratio of RNR to the average industry price book ratio of 1.10, RNR is valued more expensive than its industry peers.
VS Industry

Price/Earnings (16.12) VS Industry: 29% outperformed.

739.33
1.18

Price/Book (1.62) VS Industry: 30% outperformed.

75.45
0.08

Growth

Growth Rating

6

The Earnings Per Share has grown by an impressive 140.86% over the past year.
The Earnings Per Share is expected to grow by 66.60% on average over the next 5 years. This is a very strong growth
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
Measured over the past 5 years, RNR shows a quite strong growth in Revenue. The Revenue has been growing by 19.63% on average per year.

Based on estimates for the next 5 years, RNR will show a quite strong growth in Revenue. The Revenue will grow by 12.86% on average per year.
RNR shows a decrease in Earnings Per Share. Measured over the last 5 years, the EPS has been decreasing by -8.37% yearly.
Looking at the last year, RNR shows a small growth in Revenue. The Revenue has grown by 3.44% in the last year.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A -8.37% 140.86% 258.79% 102.36% 66.6% N/A
Revenue19.63% 6.87% 3.44% 24.53% 13.98% 12.86% N/A

Health

Health Rating

1

With a Debt to Equity ratio of 0.19, RNR is doing better than the averages in the industry. The industry average is at 0.38.
RNR has a Current Ratio of 0.69. This is a bad value and indicates that RNR is not financially healthy enough and could expect problems in meeting its short term obligations.
Compared to an average industry Current Ratio of 1.15, RNR is worse placed to pay its short term obligations than its industry peers.
RNR has a Quick Ratio of 0.69. This is a bad value and indicates that RNR is not financially healthy enough and could expect problems in meeting its short term obligations.

When comparing the Quick Ratio of RNR to the average industry Current Ratio of 1.15, RNR is less able to pay its short term obligations than its industry peers.
Based on the Altman-Z score of 0.52, we must say that RNR is in the distress zone and has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 0.65, RNR is in worse financial health than its industry peers.
VS Industry

Debt/Equity (0.19) VS Industry: 77% outperformed.

4.94
0.00

Quick Ratio (0.69) VS Industry: 29% outperformed.

0.03
8.17

Current Ratio (0.69) VS Industry: 29% outperformed.

0.03
8.17

Altman-Z (0.52) VS Industry: 31% outperformed.

-3.27
11.95

Dividend

Dividend Rating

3

The dividend of RNR is growing, but earnings are growing more, so the dividend growth is sustainable.
RNR has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of RNR has a limited annual growth rate of 4.49%.
With a yearly dividend of 0.78%, RNR is not a good candidate for dividend investing.

With a Dividend Yield of 0.78, RNR pays less dividend than the industry average, which is at 2.80. 92% of the companies listed in the same industry pay a better dividend than RNR!
With a Dividend Yield of 0.78, RNR pays less dividend than the S&P500 average, which is at 2.72.
RNR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
VS Industry

Dividend Yield (0.78%) VS Industry: 8% outperformed.

0.07
12.40

RENAISSANCERE HOLDINGS LTD

NYSE:RNR (5/26/2023, 6:49:58 PM)

After market: 190.02 +0.94 (+0.5%)

189.08

-5.59 (-2.87%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-02 2023-05-02/amc
Earnings (Next)07-24 2023-07-24/amc
Inst Owners81.37%
Inst Owner Change-4.09%
Ins Owners1.74%
Ins Owner Change8.62%
Market Cap9.50B
Analysts72.86
Price Target243.95 (29.02%)
Dividend
Industry RankSector Rank
Dividend Yield 0.78%
Dividend Growth(5Y)4.49%
DP-67.97%
Div Incr Years19
Div Non Decr Years19
Ex-Date06-14 2023-06-14 (0.38)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.48%
Min EPS beat(2)11.56%
Max EPS beat(2)13.39%
EPS beat(4)3
Avg EPS beat(4)3.28%
Min EPS beat(4)-18.6%
Max EPS beat(4)13.39%
Revenue beat(2)2
Avg Revenue beat(2)22.42%
Min Revenue beat(2)21.3%
Max Revenue beat(2)23.54%
Revenue beat(4)2
Avg Revenue beat(4)-2.27%
Min Revenue beat(4)-42.85%
Max Revenue beat(4)23.54%
PT rev (1m)-0.14%
PT rev (3m)6.06%
EPS NQ rev (1m)-1.98%
EPS NQ rev (3m)13.61%
EPS NY rev (1m)0%
EPS NY rev (3m)8.19%
Revenue NQ rev (1m)-12.07%
Revenue NQ rev (3m)-3.39%
Revenue NY rev (1m)0%
Revenue NY rev (3m)6%
Valuation
Industry RankSector Rank
PE 16.12
Fwd PE 6.53
P/S 1.48
P/FCF 5.08
P/OCF 5.08
P/B 1.62
P/tB 1.69
EV/EBITDA N/A
EPS(TTM)11.73
EY6.2%
EPS(NY)28.95
Fwd EY15.31%
FCF(TTM)37.25
FCFY19.7%
OCF(TTM)37.25
OCFY19.7%
SpS127.77
BVpS116.77
TBVpS112.06
PEG (NY)0.06
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 0.34%
ROICexc 0.35%
ROICexgc 0.42%
OM 2.52%
PM N/A
GM N/A
ROICexgc(3y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc(3y)N/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 0.61
Debt/EBITDA N/A
Cap/Depr N/A
Profit Quality N/A
Current Ratio 0.69
Quick Ratio 0.69
Altman-Z 0.52
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y140.86%
EPS 3Y-8.37%
EPS 5YN/A
EPS growth Q2Q133.14%
EPS Next Y258.79%
EPS Next 2Y102.36%
EPS Next 3Y66.6%
EPS Next 5YN/A
Revenue growth 1Y3.44%
Revenue growth 3Y6.87%
Revenue growth 5Y19.63%
Revenue growth Q2Q146.03%
Revenue Next Year24.53%
Revenue Next 2Y13.98%
Revenue Next 3Y12.86%
Revenue Next 5YN/A
EBIT growth 1Y136.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.55%
FCF growth 3Y-9.13%
FCF growth 5Y9.35%
OCF growth 1Y8.55%
OCF growth 3Y-9.13%
OCF growth 5Y9.35%
Fundamental Stock Screener Links
Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA